[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 

Topic Editors

Department of Clinical Dietetics and Human Nutrition, Faculty of Pharmaceutical Science, Josai University, 1-1 Keyakidai, Sakado 350-0295, Japan
Laboratory of Physiology, Faculty of Pharmaceutical Sciences, Josai University, 1–1 Keyakidai, Sakado, Saitama 350-0295, Japan
Department of Food and Nutritional Environment, College of Human Life and Environment, Kinjo Gakuin University, Nagoya, Japan

Nitrite and Nitric Oxide in Life

Abstract submission deadline
closed (30 June 2023)
Manuscript submission deadline
closed (31 August 2023)
Viewed by
11902

Topic Information

Dear Colleagues, 

In the process of biological evolution following oxygenic phototrophy, molecular oxygen has become the main electron acceptor during energy generation in the mitochondria of aerobic organisms on Earth. However, higher organisms have a backup system that uses nitrite as the electron acceptor for the generation of adenosine triphosphate and releases nitric oxide (NO). The release of NO dilates vessels and reduces mitochondrial oxygen consumption in ischemic tissues. There is evidence indicating that nitrite is the storage form of NO produced via canonical (NO synthase-mediated) and/or non-canonical (enterosalivary nitrate/nitrite NO) pathways and provides NO signaling under acidic, hypoxic, or physiological (e.g., gastric acidity and exercise) conditions in both cyclic guanosine monophosphate-dependent and -independent pathways. The local and systemic bioavailability of NO in the body may be closely involved in various physiological and pathological processes, including cardiovascular, musculoskeletal, neurotransmission, gastrointestinal, and host defense systems. In this regard, this Topic allows authors from different research areas to unite around one theme “Nitrite and Nitric Oxide in Life”, describe multidisciplinary applications, and develop new ideas. These collaborations could lead to the elucidation of the role of NO and nitrite in physiology and pathology for health promotion and the development of disease treatment. Therefore, we cordially invite authors to contribute original research articles and reviews that focus on this topic.

Prof. Dr. Jun Kobayashi
Dr. Kazuo Ohtake
Dr. Kunihiro Sonoda
Topic Editors

Keywords

  • nitrite
  • nitric oxide (NO)
  • NO synthase
  • mitochondria
  • enterosalivary nitrate/nitrite/NO pathway
  • aerobic/anaerobic respiration
  • ischemia/reperfusion injury

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Biology
biology
3.6 5.7 2012 16.4 Days CHF 2700
Biomedicines
biomedicines
3.9 5.2 2013 14.6 Days CHF 2600
Current Issues in Molecular Biology
cimb
2.8 2.9 1999 15.8 Days CHF 2200
International Journal of Molecular Sciences
ijms
4.9 8.1 2000 16.8 Days CHF 2900
Journal of Molecular Pathology
jmp
- - 2020 26.5 Days CHF 1000
Life
life
3.2 4.3 2011 17.8 Days CHF 2600

Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (5 papers)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
17 pages, 3777 KiB  
Article
An Evaluation of the Anti-Inflammatory Effects of a Thai Traditional Polyherbal Recipe TPDM6315 in LPS-Induced RAW264.7 Macrophages and TNF-α-Induced 3T3-L1 Adipocytes
by Phetpawi Subin, Pattraporn Sabuhom, Alisa Naladta, Prathan Luecha, Somsak Nualkaew and Natsajee Nualkaew
Curr. Issues Mol. Biol. 2023, 45(6), 4891-4907; https://doi.org/10.3390/cimb45060311 - 5 Jun 2023
Cited by 4 | Viewed by 2490
Abstract
TPDM6315 is an antipyretic Thai herbal recipe that contains several herbs with anti-inflammatory and anti-obesity activities. This study aimed to investigate the anti-inflammatory effects of TPDM6315 extracts in lipopolysaccharide (LPS)-induced RAW264.7 macrophages and TNF-α-induced 3T3-L1 adipocytes, and the effects of TPDM6315 extracts on [...] Read more.
TPDM6315 is an antipyretic Thai herbal recipe that contains several herbs with anti-inflammatory and anti-obesity activities. This study aimed to investigate the anti-inflammatory effects of TPDM6315 extracts in lipopolysaccharide (LPS)-induced RAW264.7 macrophages and TNF-α-induced 3T3-L1 adipocytes, and the effects of TPDM6315 extracts on lipid accumulation in 3T3-L1 adipocytes. The results showed that the TPDM6315 extracts reduced the nitric oxide production and downregulated the iNOS, IL-6, PGE2, and TNF-α genes regulating fever in LPS-stimulated RAW264.7 macrophages. The treatment of 3T3-L1 pre-adipocytes with TPDM6315 extracts during a differentiation to the adipocytes resulted in the decreasing of the cellular lipid accumulation in adipocytes. The ethanolic extract (10 µg/mL) increased the mRNA level of adiponectin (the anti-inflammatory adipokine) and upregulated the PPAR-γ in the TNF-α induced adipocytes. These findings provide evidence-based support for the traditional use of TPDM6315 as an anti-pyretic for fever originating from inflammation. The anti-obesity and anti-inflammatory actions of TPDM6315 in TNF-α induced adipocytes suggest that this herbal recipe could be useful for the treatment of metabolic syndrome disorders caused by obesity. Further investigations into the modes of action of TPDM6315 are needed for developing health products to prevent or regulate disorders resulting from inflammation. Full article
(This article belongs to the Topic Nitrite and Nitric Oxide in Life)
Show Figures

Figure 1

Figure 1
<p>Crude drug of the TPDM6315 recipe.</p>
Full article ">Figure 2
<p>HPLC chromatograms of TPDM6315 extracts. (<b>A</b>): AE; (<b>B</b>): EE; and (<b>C</b>): a mixture of standard substances (peak 1: gallic acid; peak 2: chebulagic acid; peak 3: ellagic acid; peak 4: chebulinic acid; peak 5: 6-gingerol; and peak 6: phellopterin).</p>
Full article ">Figure 3
<p>Effect of TPDM6315 extracts on LPS-induced-RAW264.7 macrophages. (<b>A</b>): Inhibition of nitric oxide production (the percentage of nitric oxide reduction from the LPS group). ** <span class="html-italic">p</span> &lt; 0.01 compared to the LPS group, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01: showed the significantly different effect between aqueous extract (AE) and ethanolic extract (EE), <span class="html-italic">n</span> = 3. (<b>B</b>): Cell viability of LPS-induced-macrophage RAW264.7, compared to the LPS group. No significant difference appeared. Data are presented as mean ± SD. The positive control 250 µM L-NAME was used.</p>
Full article ">Figure 4
<p>qPCR analysis of gene expression levels from the effects of TPDM6315 extracts on LPS-Induced RAW264.7 macrophages. ((<b>A</b>): iNOS; (<b>B</b>): IL-6; (<b>C</b>): PGE<sub>2</sub>; and (<b>D</b>): TNF-α. Data are presented as mean ± SD, <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 compared to the untreated group, * <span class="html-italic">p</span> &lt; 0.05 compared to the LPS-induced group using 500 ng/mL LPS for 24 h; <span class="html-italic">n</span> = 3), 250 µM L-NAME was used as a positive control. ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 5
<p>Effects of AE and EE on the percentage cell viability of 3T3-L1 adipocytes after incubation for 48 h. Data are presented as mean ± SD; ** <span class="html-italic">p</span> &lt; 0.01 compared to basal group, <span class="html-italic">n</span> = 3; 20 µM TGZ and 100 nM insulin were used as positive controls.</p>
Full article ">Figure 6
<p>Effect of TPDM6315 extracts, AE and EE, on lipid accumulation in 3T3-L1 adipocytes. The oil droplets were stained with Oil Red O and photographed using an inverted microscope (×10 magnification), ((<b>A</b>): 3T3-L1 preadipocyte; (<b>B</b>): untreated 3T3-L1 adipocyte; (<b>C</b>–<b>G</b>): treatment of AE (10, 50, 100, 200, and 400 µg/mL, respectively) during cell differentiation; (<b>H</b>–<b>L</b>): treatment of EE (10, 50, 100, 200, and 400 µg/mL, respectively) during cell differentiation; and (<b>M</b>): % reduction in intracellular oil with AE and EE in 3T3-L1 adipocyte compared to the untreated 3T3-L1 adipocyte; * <span class="html-italic">p</span> &lt; 0.05 compared to the untreated 3T3-L1 adipocyte; <span class="html-italic">n</span> = 3).</p>
Full article ">Figure 7
<p>The effect of AE and EE on relative gene expression in TNF-α-induced 3T3-L1 adipocytes. (<b>A</b>): adiponectin; and (<b>B</b>): PPAR-γ; 10 ng/mL of TNF-α was used to induce inflammation, and 20 µM troglitazone (TGZ) was a positive control. Data are presented as mean ± SD; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 compared to the untreated group; * <span class="html-italic">p</span> &lt; 0.05 and ** <span class="html-italic">p</span> &lt; 0.01 compared to the TNF-α group; <span class="html-italic">n</span> = 3.</p>
Full article ">Figure 8
<p>Effect of TPDM6315 on glucose uptake in TNF-α-induced 3T3-L1 adipocytes. (<b>A</b>): Glucose content remained in the cell culture media. (The dissimilar letter represented a significant difference between groups (<span class="html-italic">p</span> &lt; 0.05), <span class="html-italic">n</span> = 3); (<b>B</b>): relative GLUT1 expression; and (<b>C</b>): relative GLUT4 expression. TNF-α 10 ng/mL was used to induce inflammation, and 20 µM troglitazone (TGZ) was a positive control. Data are presented as mean ± SD, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, compared to the TNF-α group; <span class="html-italic">n</span> = 3. (Glucose medium was as follows: basal: 4.14; TNF-α: 4.5; TGZ: 3.5; insulin 3.6; AE100: 3.9; AE200; 4.0; EE10: 3.9; and EE50: 3.8 mg/mL).</p>
Full article ">
15 pages, 2330 KiB  
Article
Nitric Oxide Affects Heme Oxygenase-1, Hepcidin, and Transferrin Receptor Expression in the Placenta
by Patricia Principe, George T. Mukosera, Nikia Gray-Hutto, Ashra Tugung, Ciprian P. Gheorghe and Arlin B. Blood
Int. J. Mol. Sci. 2023, 24(6), 5887; https://doi.org/10.3390/ijms24065887 - 20 Mar 2023
Viewed by 2163
Abstract
Nitric oxide (NO) is a gasotransmitter that avidly binds both free and heme-bound iron, forming relatively stable iron nitrosyl compounds (FeNOs). We have previously demonstrated that FeNOs are present in the human placenta and are elevated in preeclampsia and intrauterine growth restriction. The [...] Read more.
Nitric oxide (NO) is a gasotransmitter that avidly binds both free and heme-bound iron, forming relatively stable iron nitrosyl compounds (FeNOs). We have previously demonstrated that FeNOs are present in the human placenta and are elevated in preeclampsia and intrauterine growth restriction. The ability of NO to sequester iron raises the possibility of the NO-mediated disruption of iron homeostasis in the placenta. In this work, we tested whether exposure of placental syncytiotrophoblasts or villous tissue explants to sub-cytotoxic concentrations of NO would elicit the formation of FeNOs. Furthermore, we measured changes in the mRNA and protein expression levels of key iron regulatory genes in response to NO exposure. Ozone-based chemiluminescence was used to measure concentrations of NO and its metabolites. Our results showed a significant increase in FeNO levels in placental cells and explants treated with NO (p < 0.0001). The mRNA and protein levels of HO-1 were significantly increased in both cultured syncytiotrophoblasts and villous tissue explants (p < 0.01), and the mRNA levels of hepcidin and transferrin receptor were significantly increased in culture syncytiotrophoblasts and villous tissue explants, respectively, (p < 0.01), while no changes were seen in the expression levels of divalent metal transporter-1 or ferroportin. These results suggest a potential role for NO in iron homeostasis in the human placenta and could be relevant for disorders of pregnancy such as fetal growth restriction and preeclampsia. Full article
(This article belongs to the Topic Nitrite and Nitric Oxide in Life)
Show Figures

Figure 1

Figure 1
<p>Nitric Oxide (NO) concentrations and cell viability over 24 h study period. (<b>A</b>) NO production from different concentrations of DETA in normoxic cell culture of syncytialized BeWo cells. (<b>B</b>) BeWo cell viability in response to increasing DETA concentrations under normoxia. (<b>C</b>) NO production from different concentrations of DETA in hypoxic (2% O<sub>2</sub>) cell culture of syncytialized BeWo cells. (<b>D</b>) BeWo cell viability in response to increasing DETA concentrations under hypoxia, mean ± SD, **** <span class="html-italic">p</span> &lt; 0.0001 compared to no DETA.</p>
Full article ">Figure 2
<p>NO metabolites and FeNO formation in cultured BeWo cells and villous explants after 24 h of treatment with NO (as 500 μM DETA), nitrite (250 μM), or nitrate (250 μM). (<b>A</b>) Total NOx (NO, nitrite, nitrite, FeNOs, and SNOs) in normoxic cell culture media of syncytialized BeWo cells (SCTs) following 24 h of treatment with NO, nitrite or nitrate. (<b>B</b>) NOx (NO, nitrite, FeNOs, and SNOs but not nitrate) found in homogenized syncytialized BeWo cells following 24 h treatment with NO, nitrite, or nitrate. (<b>C</b>) FeNO levels found in syncytialized BeWo cells following 24 h treatment with NO, nitrite, or nitrate. (<b>D</b>) Total NOx in culture media of human placental explants following 24 h of treatment with NO, nitrite, or nitrate. (<b>E</b>) TotalNOx found in human placental explants following 24 h treatment with NO, nitrite, or nitrate. (<b>F</b>) FeNO levels found in placental explants following 24 h treatment with NO, nitrite, or nitrate. FeNO formation is significantly increased by the presence of NO but not nitrite or nitrate. Data are reported from at least three independent experiments as mean ± SD, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, **** <span class="html-italic">p</span> &lt; 0.0001, ns = not significant.</p>
Full article ">Figure 3
<p>The effect of NO on iron handling genes in syncytialized BeWo cells. (<b>A</b>–<b>E</b>), qPCR results, and (<b>E</b>–<b>J</b>) protein analyses. Representative blots are shown in (<b>K</b>). HO-1 and HAMP mRNA levels are significantly increased in the group treated with NO compared to the untreated controls. Protein abundance of HO-1 is significantly increased in the group treated with NO compared to the untreated controls. No significant change in expression is seen in the rest of the genes studied. HO-1: heme oxygenase 1, HAMP: hepcidin antimicrobial peptide, TfR: transferrin receptor, DMT1: divalent metal transporter 1, FPN: ferroportin 1. Data are reported from at least three independent experiments as mean ± SD, ** <span class="html-italic">p</span> &lt; 0.01, **** <span class="html-italic">p</span> &lt; 0.0001, ns = not significant.</p>
Full article ">Figure 4
<p>The effect of NO on iron handling gene expression in human placental villous explants. (<b>A</b>–<b>E</b>) qPCR results, (<b>F</b>–<b>J</b>) protein analyses. Representative blots are shown in (<b>K</b>). HO-1 and TfR mRNA levels are significantly increased in the group treated with NO compared to the untreated controls. Protein abundance of HO-1 is significantly increased in the group treated with NO compared to the untreated controls. No significant change in expression is seen in the rest of the genes studied. HO-1: heme oxygenase 1, HAMP: hepcidin antimicrobial peptide, TfR: transferrin receptor, DMT1: divalent metal transporter 1, FPN: ferroportin 1. Data are reported from at least three independent experiments as mean ± SD, *** <span class="html-italic">p</span> &lt; 0.001, ns = not significant.</p>
Full article ">Figure 5
<p>NO metabolism and FeNO formation in BeWo cell culture after 24 h of treatment with NO (as 500 μM DETA), nitrite (250 μM), or nitrate (250 μM) under hypoxic conditions. (<b>A</b>) Total NOx in hypoxia cell culture media of syncytialized BeWo cells (SCTs) following 24 h of treatment. (<b>B</b>) NOx found in SCTs following 24 h treatment with NO, nitrite, or nitrate under hypoxic conditions. (<b>C</b>) FeNO levels found in SCTs following 24 h treatment with NO, nitrite, or nitrate under hypoxic conditions. FeNO formation is significantly increased following exposure to NO but not nitrite or nitrate. Data are reported from at least three independent experiments as mean ± SD, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, ns = not significant.</p>
Full article ">Figure 6
<p>The effect of hypoxia on iron handling genes in response to NO in syncitialized BeWo cells (SCTs). (<b>A</b>–<b>F</b>) qPCR results and (<b>G</b>–<b>K</b>) protein analyses. Representative blots are shown in (<b>K</b>). Hypoxia alone did not significantly alter mRNA or protein levels of any of the studied iron homeostasis markers compared to normoxic controls. (<b>A</b>,<b>B</b>) The combination of hypoxia and NO resulted in a significant increase in HO-1 and HAMP mRNA levels, while NO increased HAMP mRNA levels significantly under hypoxic conditions. No significant effect of hypoxia or NO was seen in any of the other targets studied. HO-1: Heme Oxygenase 1, HAMP: Hepcidin antimicrobial peptide, TfR: Transferrin Receptor, TF: Transferrin, DMT1, Divalent metal transporter 1, FPN: Ferroportin 1. Data are reported from at least three independent experiments as mean ± SD, * <span class="html-italic">p</span> &lt; 0.05, ns = not significant.</p>
Full article ">
12 pages, 3071 KiB  
Article
Isodorsmanin A Prevents Inflammatory Response in LPS-Stimulated Macrophages by Inhibiting the JNK and NF-κB Signaling Pathways
by You Chul Chung, Ami Lee, Jin Ah Ryuk and Youn-Hwan Hwang
Curr. Issues Mol. Biol. 2023, 45(2), 1601-1612; https://doi.org/10.3390/cimb45020103 - 13 Feb 2023
Cited by 3 | Viewed by 1847
Abstract
Natural and synthetic chalcones exhibit anti-inflammatory, antitumoral, antibacterial, antifungal, antimalarial, and antitubercular activities. Isodorsmanin A (IDA), a chalcone, is a well-known constituent of the dried seeds of Psoralea corylifolia L. (PC). Although other constituents of PC have been widely investigated, there are no [...] Read more.
Natural and synthetic chalcones exhibit anti-inflammatory, antitumoral, antibacterial, antifungal, antimalarial, and antitubercular activities. Isodorsmanin A (IDA), a chalcone, is a well-known constituent of the dried seeds of Psoralea corylifolia L. (PC). Although other constituents of PC have been widely investigated, there are no studies on the biological properties of IDA. In this study, we focused on the anti-inflammatory effects of IDA and evaluated its effects on lipopolysaccharide (LPS)-stimulated macrophages. The results showed that IDA suppressed the production of inflammatory mediators (nitric oxide [NO] and prostaglandin E2 [PGE2]) and proinflammatory cytokines (tumor necrosis factor-α [TNF-α], interleukin-6 [IL-6], and interleukin-1β [IL-1β]) without cytotoxicity. In addition, it downregulated the mRNA levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) within the treatment concentrations. In our mechanistic studies, IDA inhibited the phosphorylation of the c-Jun N-terminal kinase (JNK), mitogen-activated protein kinase (MAPK), and protected the nuclear factor of the kappa light polypeptide gene enhancer in the B-cells’ inhibitor, alpha (IκB-α), from degradation, thus preventing the activation of the nuclear factor kappa-light-chain-enhancer of activated B cells’ (NF-κB) transcription factor. Our results suggest that IDA is a promising compound for attenuating excessive inflammatory responses. Full article
(This article belongs to the Topic Nitrite and Nitric Oxide in Life)
Show Figures

Figure 1

Figure 1
<p>Effect of isodorsmanin A (IDA) on cell viability in RAW 264.7 macrophages: (<b>a</b>) The chemical structure of IDA. (<b>b</b>) Cells were pretreated with IDA (1.56, 3.13, 6.25, 12.5, or 25 μM) for 3 h and then stimulated with 100 ng/mL lipopolysaccharide (LPS) for another 21 h. The experimental values are presented as the mean ± standard error of triplicate independent experiments. * <span class="html-italic">p</span> &lt; 0.05 and ** <span class="html-italic">p</span> &lt; 0.01 indicate significant differences vs. the non-treated control (Normal).</p>
Full article ">Figure 2
<p>Effect of isodorsmanin A (IDA) on (<b>a</b>) nitric oxide (NO) and (<b>b</b>) prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) production in macrophages. Cells were pretreated with IDA (1.56, 3.13, 6.25, or 12.5 μM) for 3 h and then stimulated with 100 ng/mL of LPS for another 21 h. The experimental values are presented as the mean ± standard error of triplicate independent experiments. * <span class="html-italic">p</span> &lt; 0.05 and ** <span class="html-italic">p</span> &lt; 0.01 indicate significant differences vs. the LPS-only group. ## <span class="html-italic">p</span> &lt; 0.01 indicates significant difference vs. Normal group. Dexamethasone (Dex); positive control.</p>
Full article ">Figure 3
<p>Effect of isodorsmanin A (IDA) on (<b>a</b>) inducible nitric oxide synthase (iNOS) and (<b>b</b>) cyclooxygenase-2 (COX-2) expression levels in macrophages. Cells were pretreated with IDA (6.25 or 12.5 μM) for 3 h and then stimulated with 100 ng/mL of LPS for another 21 h. The experimental values are presented as the mean ± standard error of triplicate independent experiments. ** <span class="html-italic">p</span> &lt; 0.01 indicates a significant difference vs. the LPS-only group. ## <span class="html-italic">p</span> &lt; 0.01 indicates significant difference vs. Normal group. Dexamethasone (Dex); positive control.</p>
Full article ">Figure 4
<p>Effect of isodorsmanin A (IDA) on the expression levels of the proinflammatory cytokines: (<b>a</b>) tumor necrosis factor-α (TNF-α), (<b>b</b>) interleukin-6 (IL-6), and (<b>c</b>) interleukin-1β (IL-1β) in macrophages. Cells were pretreated with IDA (3.13, 6.25, or 12.5 μM) for 3 h and then stimulated with 100 ng/mL of LPS for another 21 h. The experimental values are presented as the mean ± standard error of triplicate independent experiments. * <span class="html-italic">p</span> &lt; 0.05 and ** <span class="html-italic">p</span> &lt; 0.01 indicate significant differences vs. the LPS-only group. ## <span class="html-italic">p</span> &lt; 0.01 indicates significant difference vs. Normal group. Dexamethasone (Dex); positive control.</p>
Full article ">Figure 5
<p>Effect of isodorsmanin A (IDA) on the phosphorylation of c-Jun N-terminal kinase (JNK) in macrophages. Cells were pretreated with IDA (6.25 or 12.5 μM) for 3 h and then stimulated with 100 ng/mL of LPS for another 2 h. Western blot results are from duplicate independent experiments. The results in the graphs are presented as the mean ± standard error from triplicate measurements. ** <span class="html-italic">p</span> &lt; 0.01 indicates significant differences vs. the LPS-only group. ## <span class="html-italic">p</span> &lt; 0.01 indicates significant difference vs. Normal group. Dexamethasone (Dex); positive control.</p>
Full article ">Figure 6
<p>Effect of isodorsmanin A (IDA) on the protein level of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)-p65 in the (<b>a</b>) cytoplasm and (<b>b</b>) nucleus of lipopolysaccharide (LPS)-stimulated macrophages. Cells were pretreated with IDA (12.5 μM) for 3 h and then stimulated with 100 ng/mL of LPS for different time intervals (30 min, 1 h, and 2 h). Western blot results are from duplicate independent experiments. The results in the graphs are presented as the mean ± standard error from triplicate measurements. Significance was tested using two-way ANOVA followed by Turkey’s post hoc test. ** <span class="html-italic">p</span> &lt; 0.01. ns; not significant.</p>
Full article ">Figure 7
<p>Effect of isodorsmanin A (IDA) on the protein levels of (<b>a</b>) phosphorylated (p)-nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)-p65, (<b>b</b>) nuclear factor of kappa light polypeptide gene enhancer in B-cells’ inhibitor, alpha (IκB-α), and p-IκB-α in macrophages. Cells were pretreated with IDA (6.25 or 12.5 μM) for 3 h and then stimulated with 100 ng/mL of LPS for another 2 h. Western blot results are from duplicate independent experiments. The results in the graphs are presented as the mean ± standard error from triplicate measurements. * <span class="html-italic">p</span> &lt; 0.05 and ** <span class="html-italic">p</span> &lt; 0.01 indicate significant differences vs. the LPS-only group. ## <span class="html-italic">p</span> &lt; 0.01 indicates significant difference vs. Normal group. Dexamethasone (Dex); positive control.</p>
Full article ">
17 pages, 3112 KiB  
Article
Uric Acid Deteriorates Load-Free Cell Shortening of Cultured Adult Rat Ventricular Cardiomyocytes via Stimulation of Arginine Turnover
by Martin Weber, Rolf Schreckenberg and Klaus-Dieter Schlüter
Biology 2023, 12(1), 4; https://doi.org/10.3390/biology12010004 - 20 Dec 2022
Cited by 4 | Viewed by 2040
Abstract
Hyperuricemia is a risk factor for heart disease. Cardiomyocytes produce uric acid via xanthine oxidase. The enzymatic reaction leads to oxidative stress in uric-acid-producing cells. However, extracellular uric acid is the largest scavenger of reactive oxygen species, specifically to nitrosative stress, which can [...] Read more.
Hyperuricemia is a risk factor for heart disease. Cardiomyocytes produce uric acid via xanthine oxidase. The enzymatic reaction leads to oxidative stress in uric-acid-producing cells. However, extracellular uric acid is the largest scavenger of reactive oxygen species, specifically to nitrosative stress, which can directly affect cells. Here, the effect of plasma-relevant concentrations of uric acid on adult rat ventricular cardiomyocytes is analyzed. A concentration- and time-dependent reduction of load-free cell shortening is found. This is accompanied by an increased protein expression of ornithine decarboxylase, the rate-limiting enzyme of the polyamine metabolism, suggesting a higher arginine turnover. Subsequently, the effect of uric acid was attenuated if other arginine consumers, such as nitric oxide synthase, are blocked or arginine is added. In the presence of uric acid, calcium transients are increased in cardiomyocytes irrespective of the reduced cell shortening, indicating calcium desensitization. Supplementation of extracellular calcium or stimulation of intracellular calcium release by β-adrenergic receptor stimulation attenuates the uric-acid-dependent effect. The effects of uric acid are attenuated in the presence of a protein kinase C inhibitor, suggesting that the PKC-dependent phosphorylation of troponin triggers the desensitizing effect. In conclusion, high levels of uric acid stress cardiomyocytes by accelerating the arginine metabolism via the upregulation of ornithine decarboxylase. Full article
(This article belongs to the Topic Nitrite and Nitric Oxide in Life)
Show Figures

Figure 1

Figure 1
<p>Effect of uric acid (UA) on cell shortening of cardiomyocytes. Cells were treated with UA for 15 min or 24 h, as indicated. Concentrations used were 1 mg/dL (UA-1) or 10 mg/dL (UA-10). Data show results for relative cell shortening (shortening amplitude [ΔL] normalized to diastolic cell length [L] and expressed as percent cell shortening (<b>A</b>), contraction velocity (Con-Vel, (<b>B</b>)) expressed in µm per s, and relaxation velocity (Rel-Vel, (<b>C</b>)) expressed in µm per s. Representative single-cell recordings for 24 h UA exposure (10 mg/dL) are given in (<b>D</b>). Data are means from n = 11 (control, 10 min), n = 10 (UA-1, 10 min), n = 6 (UA-10, 10 min), n = 24 (control, 24 h), n = 13 (UA-1, 24 h), and n = 22 (UA-10, 24 h) preparations (rats), with 4 cell culture dishes per preparation and 9 cells evaluated per cell-culture dish. Statistical analysis is based on preparations. Data are expressed as bars and whiskers with median, 25% quartile, 75% quartile indicated by bars, and complete range by whiskers. Statistical analysis is based on one-way ANOVA and Student–Newman–Keuls post hoc analysis. a, <span class="html-italic">p</span> &lt; 0.05 vs. control and UA-10; b, <span class="html-italic">p</span> &lt; 0.05 vs. control and UA-1.</p>
Full article ">Figure 2
<p>Effect of 24 h uric acid (UA) exposure on ornithine decarboxylase (ODC) and calcium-sensing-receptor (CaSR) expression. (<b>A</b>) Representative Western blot indicating the expression of ODC, CaSR, and Actin, which was used for normalization. (<b>B</b>,<b>C</b>) Quantitative analysis of ODC and CaSR expression, respectively. Data are expressed as bars and whiskers with median, 25% quartile, 75% quartile indicated by bars, and complete range by whiskers. Statistical analysis is based on one-way ANOVA and Student–Newman–Keuls post hoc analysis. a, <span class="html-italic">p</span> &lt; 0.05 vs. control. Each n = 4 as indicated in (<b>A</b>). Equal letters (a, b) indicated sample groups with <span class="html-italic">p</span> &gt; 0.05. Different letters indicate <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 3
<p>Effect of difluoromethyl ornithine (DFMO), ornithine (Orn), Nω-Hydoxy-l-arginine-acetate (Nor-NOHA), or L-N<sup>G</sup>-Nitro arginine methyl ester (L-NAME) on cell shortening and uric-acid (UA)-dependent effects. Data show the effects on cell shortening ((<b>A</b>); ΔL/L), contraction velocity ((<b>B</b>); Con Vel), and relaxation velocity ((<b>C</b>); Rel-Vel). Data are expressed as bars and whiskers with median, 25% quartile, 75% quartile indicated by bars, and complete range by whiskers. Statistical analysis is based on Student <span class="html-italic">t</span>-tests and exact <span class="html-italic">p</span>-values are indicated. Data are means from n = 10 (each) preparations (rats), with 4 cell culture dish per preparation and 9 cells evaluated per cell-culture dish. Statistical analysis is based on preparations. Two-way ANOVA was performed to exclude an interaction between the UA effects and that of the inhibitors.</p>
Full article ">Figure 4
<p>Effect of arginine supplementation on cell shortening and uric-acid (UA)-induced effects. Cells were exposed to L-arginine (Arg-1; 1 µmol/L; Arg-5, 5 µmol/L) or D-arginine (D-Arg, 5 µmol/L) and UA-10 (10 mg/dL). Data show the effects on cell shortening ((<b>A</b>); ΔL/L), contraction velocity ((<b>B</b>); Con Vel), and relaxation velocity ((<b>C</b>); Rel-Vel). Data are expressed as bars and whiskers with median, 25% quartile, 75% quartile indicated by bars, and complete range by whiskers. Statistical analysis is based on Student <span class="html-italic">t</span>-tests and exact <span class="html-italic">p</span>-values are indicated. Data are means from n = 10 (each) preparations (rats), with 4 cell culture dish per preparation and 9 cells evaluated per cell culture dish. Statistical analysis is based on preparations.</p>
Full article ">Figure 5
<p>Effect of inhibition of signal transduction pathways on cell shortening and uric-acid (UA)-induced effects. Cells were exposed to SB202190 (SB; 10 µmol/L), chelerythrine chloride (CEC, 10 µmol/L), or SP600125 (SP, 10 µmol/L) and UA-10 (10 mg/dL). Data show the effects on cell shortening ((<b>A</b>); ΔL/L), contraction velocity ((<b>B</b>); Con Vel), and relaxation velocity ((<b>C</b>); Rel-Vel). Data are expressed as bars and whiskers with median, 25% quartile, 75% quartile indicated by bars, and complete range by whiskers. Statistical analysis is based on Student <span class="html-italic">t</span>-tests and exact <span class="html-italic">p</span>-values are indicated. Data are means from n = 10 (each) preparations (rats), with 4 cell culture dish per preparation and 9 cells evaluated per cell culture dish. Statistical analysis is based on preparations.</p>
Full article ">Figure 6
<p>Effect of uric acid (UA) on calcium transients (<b>A</b>) and of calcium mobilization on UA-induced effects on cell shortening. In (<b>B</b>), extracellular calcium concentration is increased from 1.25 mmol/L (control) to 1.75 mmol/L (Ca). In (<b>C</b>), the β-adrenoceptor agonist isoprenaline (ISO, 10 nmol/L) was added. Data are expressed as bars and whiskers with median, 25% quartile, 75% quartile indicated by bars, and complete range by whiskers. Statistical analysis is based on Student <span class="html-italic">t</span>-tests and exact <span class="html-italic">p</span>-values are indicated. Data show the effects on cell shortening ((<b>A</b>); ΔL/L), contraction velocity ((<b>B</b>); Con Vel), and relaxation velocity ((<b>C</b>); Rel-Vel). Data are means from n = 5 (calcium transients) or n = 10 (<b>B</b>,<b>C</b>) preparations (rats), with 4 cell culture dish per preparation and 9 cells evaluated per cell culture dish. Statistical analysis is based on preparations. In (<b>A</b>), a representative single-cell recording for two cells is also given for 15 consecutive calcium transients.</p>
Full article ">Figure 7
<p>Effect of uric acid (UA) withdrawn for cell shortening measurements. Cells were exposed to UA for 24 h and cell shortening was analyzed in the presence of UA or after 15 min of the withdrawing of UA before starting to measure the cell shortening (WO). Data show the effects on cell shortening ((<b>A</b>); ΔL/L), contraction velocity ((<b>B</b>); Con Vel), and relaxation velocity ((<b>C</b>); Rel-Vel). Data are expressed as bars and whiskers with median, 25% quartile, 75% quartile indicated by bars, and complete range by whiskers. Statistical analysis is based on Student <span class="html-italic">t</span>-tests and exact <span class="html-italic">p</span>-values are indicated. Data are means from n = 10 (each) preparations (rats), with 4 cell culture dish per preparation and 9 cells evaluated per cell culture dish. Statistical analysis is based on preparations.</p>
Full article ">Figure 8
<p>Effect of hyperglycemia on uric-acid (UA)-induced effects on cell shortening. Cells were exposed to UA (3 mg/dL) and glucose (15 mmol/L; HG) for 24 h before analyzing cell shortening. Data show the effects on cell shortening ((<b>A</b>); ΔL/L), contraction velocity ((<b>B</b>); Con Vel), and relaxation velocity ((<b>C</b>); Rel-Vel). Data are expressed as bars and whiskers with median, 25% quartile, 75% quartile indicated by bars, and complete range by whiskers. Statistical analysis is based on Student <span class="html-italic">t</span>-tests and exact <span class="html-italic">p</span>-values are indicated. Data are means from n = 10 (each) preparations (rats), with 4 cell culture dish per preparation and 9 cells evaluated per cell culture dish. Statistical analysis is based on preparations. Equal letters (a, b) indicate sample groups with <span class="html-italic">p</span> &gt; 0.05. Different letters indicate <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 9
<p>Summary of the findings of this study and schematic overview how these data may explain the long-term effect of high concentrations of UA on the cell shortening (function) of cardiomyocytes (see <a href="#biology-12-00004-f001" class="html-fig">Figure 1</a>). High concentrations of extracellular UA (UA ↑) activate PKC-dependent pathways (PKC*), as suggested from the experiments with a PKC-inhibitor (<a href="#biology-12-00004-f005" class="html-fig">Figure 5</a>B). Subsequently, arginine uptake is affected (see <a href="#biology-12-00004-f004" class="html-fig">Figure 4</a>), ODC is induced (see <a href="#biology-12-00004-f002" class="html-fig">Figure 2</a>), and the arginine metabolism altered (<a href="#biology-12-00004-f003" class="html-fig">Figure 3</a> and <a href="#biology-12-00004-f004" class="html-fig">Figure 4</a>). Function is impaired in the presence of high intracellular calcium (see <a href="#biology-12-00004-f006" class="html-fig">Figure 6</a>).</p>
Full article ">
13 pages, 990 KiB  
Article
TRPA1 Polymorphisms Modify the Hypotensive Responses to Propofol with No Change in Nitrite or Nitrate Levels
by Isabela Borges de Melo, Gustavo H. Oliveira-Paula, Letícia Perticarrara Ferezin, Graziele C. Ferreira, Lucas C. Pinheiro, Jose E. Tanus-Santos, Luis V. Garcia, Riccardo Lacchini and Waynice N. Paula-Garcia
Curr. Issues Mol. Biol. 2022, 44(12), 6333-6345; https://doi.org/10.3390/cimb44120432 - 14 Dec 2022
Cited by 1 | Viewed by 1881
Abstract
Anesthesia with propofol is frequently associated with hypotension. The TRPA1 gene contributes to the vasodilator effect of propofol. Hypotension is crucial for anesthesiologists because it is deleterious in the perioperative period. We tested whether the TRPA1 gene polymorphisms or haplotypes interfere with the [...] Read more.
Anesthesia with propofol is frequently associated with hypotension. The TRPA1 gene contributes to the vasodilator effect of propofol. Hypotension is crucial for anesthesiologists because it is deleterious in the perioperative period. We tested whether the TRPA1 gene polymorphisms or haplotypes interfere with the hypotensive responses to propofol. PCR-determined genotypes and haplotype frequencies were estimated. Nitrite, nitrates, and NOx levels were measured. Propofol induced a more expressive lowering of the blood pressure (BP) without changing nitrite or nitrate levels in patients carrying CG+GG genotypes for the rs16937976 TRPA1 polymorphism and AG+AA genotypes for the rs13218757 TRPA1 polymorphism. The CGA haplotype presented the most remarkable drop in BP. Heart rate values were not impacted. The present exploratory analysis suggests that TRPA1 genotypes and haplotypes influence the hypotensive responses to propofol. The mechanisms involved are probably other than those related to NO bioavailability. With better genetic knowledge, planning anesthesia with fewer side effects may be possible. Full article
(This article belongs to the Topic Nitrite and Nitric Oxide in Life)
Show Figures

Figure 1

Figure 1
<p>Effects of TRPA1 genotypes on blood pressure (BP) changes in response to propofol. (<b>A</b>) Effects of the CC (<span class="html-italic">n</span> = 127) and TC (<span class="html-italic">n</span> = 35) genotypes for the rs920829 polymorphism on changes in systolic, mean, and diastolic BP in response to propofol. (<b>B</b>) Effects of the CC (<span class="html-italic">n</span> = 119) and CG+GG (<span class="html-italic">n</span> = 44) genotypes for the rs16937976 polymorphism on changes in systolic, mean, and diastolic BP in response to propofol. (<b>C</b>) Effects of the GG (<span class="html-italic">n</span> = 120) and AG+AA (<span class="html-italic">n</span> = 42) genotypes for the rs13218757 polymorphism on changes in systolic, mean, and diastolic BP in response to propofol. Data are shown as means ± SEMs. * <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 2
<p>Effects of TRPA1 haplotypes on changes in systolic, mean, and diastolic blood pressure (BP) in response to propofol. CCG (<span class="html-italic">n</span> = 240), CGA (<span class="html-italic">n</span> = 46), and TCG (<span class="html-italic">n</span> = 31). Data are shown as means ± SEMs. * <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 3
<p>Impact of TRPA1 genotypes on alterations in NOx, nitrite, and nitrate concentrations induced by propofol. (<b>A</b>) Effects of the CC (<span class="html-italic">n</span> = 127) and CG (<span class="html-italic">n</span> = 35) genotypes for the rs920829 SNP. (<b>B</b>) Effects of the CC (<span class="html-italic">n</span> = 119) and CG+GG (<span class="html-italic">n</span> = 44) genotypes for the rs16937976 SNP. (<b>C</b>) Effects of the GG (<span class="html-italic">n</span> = 120) and AG+AA (<span class="html-italic">n</span> = 42) genotypes for the rs13218757 SNP. Data are shown as means ± SDs.</p>
Full article ">
Back to TopTop